Jemma Arakelyan, Chief Executive Officer at The Institute of Cancer and Crisis (ICC) and Medical Advisor at Immune Oncology Research Institute, and Clinical Research Specialist at Laboratory for Synthetic Chemistry and Chemical Biology, shared a post on LinkedIn:
“It’s that time of year again for two of my favorite events. Belt and Road Initiative Summit and BIOHK 2025.
As a Belt and Road scholar, the summit is a profound annual opportunity to engage with the future of global connectivity and cooperation.
And BioHK25 is simply unparalleled – a unique convergence where you can find everything from groundbreaking industry innovations to news that is actively reshaping clinical practice.”
More posts featuring Jemma Arakelyan,